Chikungunya, a mosquito-borne virus found mainly in tropical and subtropical regions, was locally acquired in New York.

“Antibiotic resistance is widespread and threatening the future of modern medicine,” Dr. Yvan Hutin, director of WHO’s Department of Antimicrobial Resistance, told The New York Times. “Simply put, the ...

New code E11.A applies to patients who use lifestyle interventions to show no signs of type 2 diabetes for at least 3 months.

Implementation of a new definition of obesity proposed by a recent Lancet Commission increases the prevalence of obesity.

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.